Diagnosing Disease with a Snapshot

December 6, 2016

(MIT Technology Review) – FDNA, Face2Gene’s parent company, began six years ago after the Israeli cofounders sold their previous facial recognition company, Face.com, to Facebook. That technology is able to differentiate specific individuals by being “trained” on multiple images of that person. Face2Gene’s technology, in contrast, identifies a pattern that is common to a group of people that have the same syndrome; establishing that common denominator allows the software to create a composite image associated with a condition.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.